With the current levels of concern and uncertainty over the Coronavirus COVID-19, this is now a digital event.
The RDD conference series impacts regulatory and scientific policies worldwide and is recognized as one of the premier international meetings in this area. With over 500 participants expected to attend, RDD is devoted to innovative research, technology and services relevant to the aerosol community.
Going to RDD 2020?
Our track record speaks volumes. Creating innovative respiratory drug delivery devices, including digitally enhanced connected devices, is a key part of our business.
Our scientists, engineers, human factors specialists, designers and manufacturing experts work across a variety of disciplines. So, cross-fertilisation of ideas is business as usual. And because we’ve been around for more than 50 years, we’re used to working within the framework of risk management, quality systems and regulatory affairs.
Meet our team at RDD and explore how we can help you develop your next drug delivery device.